Comments
The API manufacturing facility of JB Chemicals & Pharmaceuticals at Panoli, Gujarat, has successfully passed a periodical inspection by the USFDA with two minor procedural observations. “These observations do not impact the continuity of the company’s business and the company would continue its manufacturing activities in a cGMP-compliant manner. The company proposes to address these observations in the next 30 days. The said inspection was carried out from 7-5-2018 to 11-5-2018,” it said in a statement. The USFDA/EU/Japan-approved active pharmaceutical ingredient (AP) facility, primarily manufactures APIs for the EU and formulations for the US markets. Shares of JB Chemicals slipped a little over 1 per cent at ₹316.05 on the NSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.